Drug Diversion Prevention in Healthcare

Bookmark and Share

Drug Diversion Prevention in Healthcare

Product Code: DDH

Availability: In stock

Your Price:
$155.00
each
Add Items to Cart

Drug Diversion Prevention in Healthcare

Kimberly New, BSN, JD

Theft of controlled substances at hospitals has always been a problem of paramount importance, but even with increased security measures, it still occurs. Drug Diversion Prevention in Healthcare discusses the issue of drug diversion in detail and demonstrates the components of a solid prevention plan. Loaded with tools and checklists, this book is designed to help hospital security officials create awareness of the drug diversion problem. You will learn how to design a program to keep staff accountable for drug administrations, as well as audits that monitor drug distribution from delivery to patient administration.

This resource will help you: 

  • Establish an effective drug diversion prevention plan among hospital staff 
  • Understand the fundamental issues of drug diversion 
  • Create awareness among staff using tools and checklists 
  • Learn to recognize suspected diverters and mitigate problem areas in your hospital 
  • Effectively confront and deal with diverters in your facility 


About the Author:

Kimberly New, BSN, JD, is a consultant to healthcare institutions on the subject of drug security and diversion. She is the founder and principal consultant of Diversion Specialists, a firm that specializes in preventing, detecting, and responding to drug diversion by healthcare personnel. New is a nurse and an attorney, with extensive clinical experience as a nurse as well as many years of experience as a healthcare lawyer. She has also worked as a compliance officer at both a large long-term care company and an academic medical center.

Published: November 2016

Page Count: 150

Dimensions: 8.5 X 11
ISBN: 978-1-55645-937-5

Table of Contents


Chapter 1: Introduction to Drug Diversion

Scope of the Problem
Risks Associated With Diversion
Regulatory Requirements and Considerations


Chapter 2: Establishing a Prevention Program

Diversion Oversight Committees
Stakeholders

Nursing and Pharmacy
Anesthesia
Security
Risk Management and Quality
Accreditation
Chief Medical Officer
Compliance
Infection Prevention
Human Resources and Employee Health
Finance
Research
Ad-Hoc Members

Diversion Response Teams
Diversion Specialists
Gaining Buy-In to the Program
Developing a Systemwide Approach


Chapter 3: Regulatory Requirements and Best Practices

Patient Safety
Patient Privacy
Security and Medication Handling Requirements
Recordkeeping
Diversion Investigation and Response
CEO and Board Communication


Chapter 4: Staff Education

Pharmacy Staff
Managers
Charge Nurses and Team Leaders
Physicians and Midlevel Provider Staff


Chapter 5: Diversion Risk Rounds

Risk Rounds in the Pharmacy
Risk Rounds in Nursing Units
Risk Rounds in Operative and Procedural Areas
Risk Rounds in Medical Offices


Chapter 6: Surveillance and Physical Security

Video Surveillance
Badges and Electronic Measures
Transportation Security
Access Restriction
Drug Cabinets


Chapter 7: Patterns of Drug Diversion

Commonly Diverted Drugs
Identifying and Managing Noncompliance
The Problem of “Pre-Pulling”
Handoffs
Travelers and Agency Workers


Chapter 8: Special Considerations

Pharmacy

Procurement
Recordkeeping
Stocking and Reprocessing Return Bins
Closing the Loop
Waste and Reverse Distribution
Keys
Inventories
Discrepancies
Controlled Substance Overrides
Patient-Specific Controlled Substances
Specialized Monitoring
Controlled Substances for EMS Providers
Outpatient Pharmacy Considerations

Physician Office Practices
Samples
Prescription Control

Prescription pads

PCA and Controlled Substance Drips
Labor and Delivery
Anesthesia, Surgery, and Procedural Areas
OR Pharmacy


Chapter 9: When to Suspect Diversion

Characteristics of a Diverter
Patterns of Diversion
Automated Drug Cabinet Reports


Chapter 10: Methods of Diversion

Diversion by Falsified Records
Tampering and Substitution
Best Practices are the Best Prevention
Waste in the Pharmacy
Regulatory Matters Related to Waste
Assessing Controlled Waste Practices for Diversion Risk


Chapter 11: Investigation of Suspected Diversion

Establishing Reasonable Suspicion and Protecting Patients
Interviewing Suspected Diverters
Drug Testing


Chapter 12: Response to Confirmed Diversion

Termination
Internal Reporting
External Reporting
Prosecution and Public Notification
Patient Privacy Considerations
Root-Cause Analysis
Barriers to Diversion Response


Appendixes:

Appendix A: Basic Auditing Components Outline
Appendix B: Recognizing Drug Diversion in Healthcare Facilities
Appendix C: Consent to Draw Blood for HIV, HBV, and HCV Infectivity Testing
Appendix D: Sample Diversion Oversight Committee Charter
Appendix E: Diversion Program Structure
Appendix F: Diversion Risk Rounds Checklist
Appendix G: Sample Diversion Specialist Job Description